440 related articles for article (PubMed ID: 16045774)
1. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Ryan R; Gibbons D; Hyland JM; Treanor D; White A; Mulcahy HE; O'Donoghue DP; Moriarty M; Fennelly D; Sheahan K
Histopathology; 2005 Aug; 47(2):141-6. PubMed ID: 16045774
[TBL] [Abstract][Full Text] [Related]
2. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
3. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
5. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
6. Rectal cancer staging post neoadjuvant therapy--how should the changes be assessed?
Bateman AC; Jaynes E; Bateman AR
Histopathology; 2009 May; 54(6):713-21. PubMed ID: 19438746
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients.
Box B; Lindsey I; Wheeler JM; Warren BF; Cunningham C; George BD; Mortensen NJ; Jones AC
Dis Colon Rectum; 2005 Jun; 48(6):1153-60. PubMed ID: 15868236
[TBL] [Abstract][Full Text] [Related]
9. Effects of radiotherapy on different histopathological types of rectal carcinoma.
Sengul N; Wexner SD; Woodhouse S; Arrigain S; Xu M; Larach JA; Ahn BK; Weiss EG; Nogueras JJ; Berho M
Colorectal Dis; 2006 May; 8(4):283-8. PubMed ID: 16630231
[TBL] [Abstract][Full Text] [Related]
10. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
[TBL] [Abstract][Full Text] [Related]
11. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
13. The role of local excision in rectal cancer after complete response to neoadjuvant treatment.
Coco C; Manno A; Mattana C; Verbo A; Rizzo G; Valentini V; Gambacorta MA; Vecchio FM; D'Ugo D
Surg Oncol; 2007 Dec; 16 Suppl 1():S101-4. PubMed ID: 18023178
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
[TBL] [Abstract][Full Text] [Related]
15. Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer.
Caricato M; Ausania F; De Dominicis E; Vincenzi B; Rabitti C; Tonini G; Cellini F; Coppola R
Eur J Surg Oncol; 2007 Aug; 33(6):724-8. PubMed ID: 17336482
[TBL] [Abstract][Full Text] [Related]
16. Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?
Park SY; Chang HJ; Kim DY; Jung KH; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
Histopathology; 2011 Oct; 59(4):650-9. PubMed ID: 22014046
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
[TBL] [Abstract][Full Text] [Related]
18. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
19. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
[TBL] [Abstract][Full Text] [Related]
20. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
